Enhanced blood pressure sensitivity to DOCA-salt treatment in endothelin ET(B) receptor-deficient rats

• Published in: British journal of pharmacology Vol. 129; no. 6; pp. 1060 - 1062
• Main Authors: Matsumura, Y, Kuro, T, Konishi, F, Takaoka, M, Gariepy, C E, Yanagisawa, M
• Format: Journal Article
• Language: English
• Published: England 01-03-2000
• Subjects: Animals; Blood Pressure - drug effects; Body Weight - drug effects; Creatinine - blood; Creatinine - urine; Desoxycorticosterone - pharmacology; Dopamine beta-Hydroxylase - deficiency; Dopamine beta-Hydroxylase - genetics; Kidney Function Tests; Male; Nephrectomy; Organ Size - drug effects; Rats; Receptor, Endothelin B; Receptors, Endothelin - deficiency; Receptors, Endothelin - genetics
• ISSN: 0007-1188
• DOI: 10.1038/sj.bjp.0703157

The role of endothelin ET(B) receptor-mediated action in the development and maintenance of deoxycorticosterone acetate (DOCA)-salt-induced hypertension was evaluated using the spotting-lethal (sl) rat which carries a naturally occurring deletion in the ET(B) receptor gene. Homozygous (sl/sl) rats treated with DOCA-salt for 1 week exhibited an earlier onset of hypertension than heterozygous (sl/+) and wild-type (+/+) rats (systolic blood pressure, SBP; 156.7+/-3.4 versus 128.8+/-5.3 and 132.9+/-3.7 mmHg, respectively). Four weeks after the start of DOCA-salt treatment, homozygous rats developed marked hypertension, with a SBP of 206. 0+/-4.5 mmHg, compared with 184.8+/-10.7 mmHg in heterozygous and 164.3+/-4.8 mmHg in wild-type rats. Cardiovascular hypertrophy and renal dysfunction observed after 4-weeks treatment with DOCA-salt were more severe in homozygous rats, compared to wild-type and heterozygous animals. These evidences support strongly the view that ET(B) receptor-mediated actions are a protective factor in the pathogenesis of DOCA-salt-induced hypertension.